Charcot-Marie-Tooth disease type 4A

Charcot-Marie-Tooth disease type 4A (CMT4A) is a subtype of Charcot-Marie-Tooth disease type 4 characterized by early-onset (infancy to early childhood) of severe, rapidly progressing demyelinating, axonal, or intermediate sensorimotor neuropathy usually affecting first, and more severely, the distal lower extremities and later the proximal muscles and upper extremities. Nerve conduction velocities range from very slow to normal. Apart from the typical CMT phenotype (distal muscle weakness and atrophy, sensory loss, frequent pes cavus foot deformity), patients commonly present delayed motor development, vocal cord paresis, mild sensory loss, abolished deep tendon reflexes, and skeletal deformities.

Also known as: CMT4A, Charcot-Marie-Tooth disease type 4 caused by mutation in GDAP1, GDAP1 Charcot-Marie-Tooth disease type 4, Charcot Marie Tooth disease type 4A, Charcot-Marie-Tooth disease, demyelinating, autosomal recessive, Charcot-Marie-Tooth disease, demyelinating, autosomal recessive, type 4A, Charcot-Marie-Tooth disease, type 4A, Charcot-Marie-Tooth neuropathy, type 4A

9 clinical trials for this condition and its sub-types, 2 tagged with Charcot-Marie-Tooth disease type 4A itself.